Shanming Ruan

Zhejiang Provincial Hospital of Chinese Medicine

H指数:21

被引数:1,908

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ailanthone targets the EGR3-SOCS2 regulatory pathway to suppress vasculogenic mimicry in prostate cancer

AILANTHONE靶向EGR3-SOCS2调控通路以抑制前列腺癌中的血管生成拟态

Biochemical Pharmacology

IF5.6

2026-04-150

PRE

Jiedu Sangen Decoction inhibits Epithelial-mesenchymal transition of colon adenocarcinoma via POU4F2/Hedgehog pathway

解毒三根汤通过POU4F2/Hedgehog通路抑制结肠腺癌的上皮-间质转化

Journal of Ethnopharmacology

IF5.4

2025-10-150

PRE

MicroRNA-23b: Roles, functions and mechanisms in tumor

MicroRNA-23b：在肿瘤中的作用、功能与机制

Genes & Diseases

IF9.4

2025-09-180

OAAI

Construction of a risk prediction model for early postoperative recurrence in stage II/III colorectal cancer

构建结直肠癌II/III期术后早期复发风险预测模型

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY

IF2.5

2025-09-150

Luteolin Induces GPX4-dependent Ferroptosis and Enhances Immune Activation in Colon Cancer

木犀草素诱导GPX4依赖性铁死亡并增强结肠癌的免疫激活

Phytomedicine

IF8.3

2025-07-280

PRE

Bioactive components of Jiedu Sangen decoction against colorectal cancer: A novel and comprehensive research strategy for natural drug development

解毒三根汤抗结直肠癌的生物活性成分：一种用于天然药物开发的新型综合研究策略

PHYTOMEDICINE

IF8.3

2025-07-010

PRE

Alcohol consumption and risk of early onset colorectal cancer: A systematic review and meta-analysis

酒精摄入与早发性结直肠癌风险：一项系统评价和荟萃分析

COLORECTAL DISEASE

IF2.7

2025-03-240

PRE

Comprehensive bioinformatics and experimental analysis of SH3PXD2B reveals its carcinogenic effect in gastric carcinoma

LIFE SCIENCES

IF5.1

2023-08-014

PRE

Regulation of hPCL3 isoforms' ubiquitination by TRIM21 in non-small cell lung cancer progression

LIFE SCIENCE ALLIANCE

IF2.9

2023-07-280

OAAI

Clinical prognostic value of OSGIN2 in gastric cancer and its proliferative effect in vitro

SCIENTIFIC REPORTS

IF3.9

2023-04-083

OAAI

The antitumor properties of atractylenolides: Molecular mechanisms and signaling pathways

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-11-018

OAAI

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial-mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway (vol 20, pg 2783, 2019)

MOLECULAR MEDICINE REPORTS

IF3.5

2022-10-101

OAAI

The new exploration of pure total flavonoids extracted from Citrus maxima (Burm.) Merr. as a new therapeutic agent to bring health benefits for people

FRONTIERS IN NUTRITION

IF5.1

2022-10-0612

OAAI

Association Between Metabolic Syndrome and Risk of Renal Cell Cancer: A Meta-Analysis

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-278

OAAI

What Causes Death in Esophageal Cancer Patients Other Than the Cancer Itself: A Large Population-Based Analysis

JOURNAL OF CANCER

IF3.2

2022-01-017

OAAI

Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma (vol 10, 595354, 2020)

用于预测早发性结肠腺癌患者的总体生存率和癌症特异性生存率的预后列线图 (第10卷，595354，2020)

FRONTIERS IN ONCOLOGY

IF3.3

2021-12-221

OAAI

Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report

中药皮艳宁成功治疗stevens-johnson综合征/中毒性表皮坏死松解症1例

JOURNAL OF INTEGRATIVE MEDICINE-JIM

IF4

2021-11-014

PRE

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors

FRONTIERS IN ONCOLOGY

IF3.3

2021-04-1619

OAAI

Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-3020

OAAI

Association of Survival and Immune-Related Adverse Events With Anti-PD-1/PD-L1 and Anti-CTLA-4 Inhibitors, Alone or Their Combination for the Treatment of Cancer: A Systematic Review and Meta-Analysis of 13 Clinical Trials

Anti-PD-1/PD-L1和Anti-CTLA-4抑制剂单独或联合治疗癌症与生存和免疫相关不良事件的关系: 13项临床试验的系统评价和荟萃分析

FRONTIERS IN ONCOLOGY

IF3.3

2021-02-259

OAAI

Shanming Ruan

个人简介

教育背景

工作经历

荣誉奖项

研究方向